
Unigrilin 75 Injection
Marketer
United Biotech Pvt Ltd
Salt Composition
Eptifibatide (75mg)
Overview Unigrilin 75 Injection
Heparin 75 Injection is an anticoagulant preventing the development of dangerous blood clots. It's employed in acute myocardial infarction treatment and to hinder intracoronary thrombosis during angioplasty (a procedure enhancing coronary blood flow). Administration is strictly under medical supervision; dosage and treatment length are determined by your physician. Continue all prescribed medications, regardless of this injection. Thrombocytopenia and increased bleeding risk are potential side effects. Report petechiae or hematuria/hematochezia promptly. Hypotension is another possible adverse reaction. Your doctor will discuss the benefits and risks before treatment begins. Caution is warranted in certain patients. Disclose any bleeding disorders, hepatic or renal impairment, pregnancy, breastfeeding, or concurrent medications prior to use.
Primary Ingredients of Unigrilin 75 Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Unigrilin 75 Injection
Thrombosis prophylaxis | Myocardial infarction prevention
Major Benefits of Unigrilin 75 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Unigrilin 75 Injection:
- Bleeding
- Decreased blood pressure
How to use Unigrilin 75 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Unigrilin 75 Injection works:
Roplat 75 Injection is an antithrombotic agent that inhibits platelet aggregation, thus reducing the risk of dangerous thrombus development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Unigrilin 75 Injection is undetermined; therefore, medical advice is recommended before combining them.
PregnancySAFE IF PRESCRIBED
The administration of Unigrilin 75 Injection during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
The use of Unigrilin 75 Injection while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingNOT RELEVANT
Irrelevant, given Unigrilin 75 Injection's exclusive application within a hospital setting.
KidneyCAUTION
For individuals with impaired kidney function, Unigrilin 75 Injection requires careful administration and may necessitate dose modification. Physician consultation is advised. Unigrilin 75 Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Unigrilin 75 Injection's use in individuals with hepatic impairment. Physician consultation is advised. Unigrilin 75 Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Unigrilin 75 Injection :
Omitting a scheduled Unigrilin 75 Injection necessitates contacting your physician.
Facts to Know About Unigrilin 75 Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide and Amino Acid Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | IIb/IIIa receptor antagonists |
